Leishmania mexicana Centrin Knock out Parasites Promote M1-polarizing Metabolic Changes

Abstract

ABSTRACTLeishmaniasis is a tropical disease present in more than 90 countries. Presently, there is no approved vaccine for human use. We have previously developed live attenuated L. mexicana Cen−/− (LmexCen−/−) as a vaccine candidate that showed excellent efficacy that was characterized by reduced activation of Th2 responses and enhanced Th1 responses, contrary to wild type L. mexicana (LmexWT) infection. Towards understanding the interplay between immune mechanisms of protection and metabolic reprogramming, we applied untargeted mass spectrometric analysis to LmexCen−/− and compared them with LmexWT infection. Data showed that enriched pentose phosphate pathway (PPP) in ears immunized with LmexCen−/− parasites, compared to naïve and LmexWT-infected ears. This pathway is known to promote an M1 phenotype in macrophages, suggesting a switch to a pro-inflammatory phenotype following LmexCen−/− inoculation. Accordingly, inhibition of the PPP in macrophages cultured with LmexCen−/− parasites led to diminished production of nitric oxide, IL-12, and IL-1β, hallmarks of classical activation. Overall, our study revealed novel immune regulatory mechanisms that may be critical for the induction of protective immunity.